New Jersey SR 25: Urges FDA to make naloxone available over the counter.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2020-01-30)

State: New Jersey · Session: 219 · Bill: SR 25

Subjects: DRUG ABUSE, PHARMACEUTIC

Sponsors: Vitale, Joseph F.

View New Jersey SR 25 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.